imiquimod has been researched along with 9,10-dimethyl-1,2-benzanthracene in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nafz, J; Nindl, I; Ohnesorge, M; Rösl, F; Stockfleth, E | 1 |
| Chrisovergis, A; Eleftheriadou, A; Ferekidou, E; Gkoulioni, V; Kandiloros, D; Lazaris, ACh; Yiotakis, I | 1 |
| de C Monteiro, JS; de Oliveira, SC; de Souza, SC; dos Santos, JN; Gurgel, CA; Pinheiro, AL; Reis Júnior, JA | 1 |
| Cataisson, C; Day, CP; Flowers, B; Fraser, E; Li, L; Sanchez, V; Yuspa, SH | 1 |
4 other study(ies) available for imiquimod and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
Imiquimod treatment of papilloma virus and DMBA /TPA-induced cutaneous skin cancer in Mastomys coucha: an unique animal model system useful for preclinical studies.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoquinolines; Animals; Antineoplastic Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Imiquimod; Murinae; Papilloma; Papillomavirus Infections; Skin Neoplasms; Tetradecanoylphorbol Acetate; Treatment Outcome | 2007 |
The efficacy of imiquimod on dysplastic lesions of the oral mucosa: an experimental model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoquinolines; Animals; Antineoplastic Agents; Carcinogens; Carcinoma, Squamous Cell; Imiquimod; Male; Mouth Mucosa; Mouth Neoplasms; Precancerous Conditions; Rats; Rats, Wistar | 2010 |
Effects of imiquimod and low-intensity laser (λ660 nm) in chemically induced oral carcinomas in hamster buccal pouch mucosa.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoquinolines; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cheek; Combined Modality Therapy; Cricetinae; Imiquimod; Low-Level Light Therapy; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms | 2013 |
Topical Application of a Dual ABC Transporter Substrate and NF-κB Inhibitor Blocks Multiple Sources of Cutaneous Inflammation in Mouse Skin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Humans; Imiquimod; Inflammation; Keratinocytes; Mice; NF-kappa B; Nicotinic Acids; Nitriles; Piperidines; Pyrrolidines; Skin; Skin Neoplasms | 2019 |